Janus Henderson Group PLC Trims Position in Masimo Co. (MASI)

Janus Henderson Group PLC lowered its holdings in Masimo Co. (NASDAQ:MASI) by 0.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 456,494 shares of the medical equipment provider’s stock after selling 2,593 shares during the quarter. Janus Henderson Group PLC’s holdings in Masimo were worth $56,852,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. FMR LLC grew its position in Masimo by 6,605.4% in the 2nd quarter. FMR LLC now owns 1,821,994 shares of the medical equipment provider’s stock valued at $177,918,000 after purchasing an additional 1,794,822 shares during the period. American Century Companies Inc. grew its position in Masimo by 932.6% in the 3rd quarter. American Century Companies Inc. now owns 850,436 shares of the medical equipment provider’s stock valued at $105,913,000 after purchasing an additional 768,078 shares during the period. Schroder Investment Management Group grew its position in Masimo by 77.2% in the 2nd quarter. Schroder Investment Management Group now owns 799,435 shares of the medical equipment provider’s stock valued at $106,225,000 after purchasing an additional 348,169 shares during the period. Victory Capital Management Inc. grew its position in Masimo by 43.4% in the 3rd quarter. Victory Capital Management Inc. now owns 641,074 shares of the medical equipment provider’s stock valued at $79,838,000 after purchasing an additional 194,055 shares during the period. Finally, Renaissance Technologies LLC grew its position in Masimo by 8.0% in the 2nd quarter. Renaissance Technologies LLC now owns 552,626 shares of the medical equipment provider’s stock valued at $53,964,000 after purchasing an additional 41,126 shares during the period. 88.00% of the stock is owned by institutional investors and hedge funds.

Several analysts recently issued reports on the stock. Stifel Nicolaus lifted their price target on shares of Masimo from $112.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 2nd. Needham & Company LLC assumed coverage on shares of Masimo in a research report on Friday, September 14th. They issued a “buy” rating for the company. BidaskClub raised shares of Masimo from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 17th. Piper Jaffray Companies lifted their price target on shares of Masimo to $120.00 and gave the company a “neutral” rating in a research report on Thursday, November 1st. Finally, Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Friday, November 16th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Masimo currently has an average rating of “Buy” and an average target price of $119.00.

In other Masimo news, CEO Joe E. Kiani sold 200,555 shares of the firm’s stock in a transaction on Monday, September 17th. The stock was sold at an average price of $122.92, for a total transaction of $24,652,220.60. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Joe E. Kiani sold 239,926 shares of the firm’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $117.95, for a total value of $28,299,271.70. Following the transaction, the chief executive officer now owns 236,061 shares in the company, valued at $27,843,394.95. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 569,106 shares of company stock worth $68,242,221. Company insiders own 12.60% of the company’s stock.

Shares of NASDAQ:MASI opened at $110.42 on Friday. Masimo Co. has a 1-year low of $80.69 and a 1-year high of $126.89. The firm has a market cap of $5.80 billion, a price-to-earnings ratio of 45.07, a P/E/G ratio of 2.41 and a beta of 1.11.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.02. Masimo had a return on equity of 20.29% and a net margin of 17.08%. The business had revenue of $210.58 million for the quarter, compared to analysts’ expectations of $207.62 million. During the same period last year, the business earned $0.56 EPS. The business’s revenue was up 8.9% on a year-over-year basis. On average, equities research analysts anticipate that Masimo Co. will post 2.92 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Janus Henderson Group PLC Trims Position in Masimo Co. (MASI)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.com-unik.info/2018/12/01/janus-henderson-group-plc-trims-position-in-masimo-co-masi.html.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Article: How Do Tariffs Affect Trade Balances?

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit